MedPath

Rectal Cancer Trial On Defunctioning Stoma

Completed
Conditions
Rectal Cancer
Registration Number
NCT00636948
Lead Sponsor
Rectal Cancer Trial on Defunctioning Stoma Study Group
Brief Summary

The hypothesis of the present trial was that the use of a defunctioning loop stoma reduces the rate of symptomatic anastomotic leakage from 15% to 7.5% after low anterior resection of the rectum for cancer.

Detailed Description

The assumption that a defunctioning loop stoma reduces symptomatic anastomotic leakage from 15% to 7.5%, with a level of statistical significance of 5% and a statistical power of 80%, requires randomization of 220 patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
234
Inclusion Criteria
  • Absence of intraoperative adverse events according to the study protocol and the operating surgeon.
Exclusion Criteria
  • Presence of intraoperative adverse events according to the study protocol and the operating surgeon.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptomatic anastomotic leakage following low anterior resection of the rectum for cancer with and without a defunctioning stoma. Anorectal function after one and five years without defunctioning stoma.30 days, one year and five years.
Secondary Outcome Measures
NameTimeMethod
Reoperation within 30 days of initial surgery.30 days

Trial Locations

Locations (1)

Department of Surgery, Linköping University Hospital

🇸🇪

Linköping, Sweden

© Copyright 2025. All Rights Reserved by MedPath